trending Market Intelligence /marketintelligence/en/news-insights/trending/kBK9JK8dOY5Eh6WNW-GEUg2 content esgSubNav
In This List

Interpace Diagnostics to raise $1.7M in offering

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Interpace Diagnostics to raise $1.7M in offering

Interpace Diagnostics Group Inc. is issuing 2 million shares and 1.6 million pre-funded warrants to an undisclosed buyer to raise $1.7 million in net proceeds.

The shares are priced at 53 cents apiece while the warrants are exercisable at 52 cents per share.

Maxim Group LLC is the exclusive placement agent for the registered direct offering which is expected to close Dec. 22.

Funds raised will help Interpace meet working capital requirements.